John T. Curnutte, Executive Vice President at PORTOLA PHARMACEUTICALS INC (PTLA), sold 10,000 shares at $26.00 ($260K) on 2014-06-16, disclosed to the SEC on 2014-06-16.
Scheduled sale ($260k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PTLA | SELL | 2015-07-15 | $500K | — | Filing → |
| PTLA | SELL | 2015-06-22 | $475K | — | Filing → |
| PTLA | SELL | 2015-06-17 | $450K | — | Filing → |